Current, New and Future Treatments in Dyslipidaemia and Atherosclerosis

Author： Chong P.H.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.60, Iss.1, 2000-07, pp. : 55-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is the future for drug development in atherosclerosis and dyslipidaemia?

By Suckling Keith  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for dyslipidaemia – current therapies and future agents

By Bays Harold   Stein Evan A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 1901-1938

Informa Healthcare

Access to resources Recommend Favorite

Current and future treatments of bone metastases

By Clark JCM   Dass CR   Choong Peter FM  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 609-627

Informa Healthcare

Access to resources Recommend Favorite

Current and Future Drug Treatments for Glioblastomas

By  

Current Medicinal Chemistry, Vol. 23, Iss. 38, 2016-12 ,pp. : 4309-4316

Bentham Science Publishers

Access to resources Recommend Favorite

Trigeminal neuralgia: current treatments and future developments

By Fisher Andrew   Zakrzewska Joanna M   Patsalos Philip N  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 123-143

Informa Healthcare

Access to resources Recommend Favorite